In silico CROs support pharma and biotech by offering computational services like molecular modeling, virtual screening, and pharmacokinetic analysis. They play a key role in personalized medicine by leveraging AI, machine learning, and molecular dynamics. These tools help predict drug interactions, toxicity, and molecular behavior, speeding up drug discovery and enabling safer, targeted treatments.

For Sample Report: https://tinyurl.com/43aeue...

Which of the following is NOT a service offered by in silico CROs?